Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8389578 Composition and method for treating neurological disease

Patent 8389578 was granted and assigned to Adamas Pharmaceuticals, Inc. on March, 2013 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

8389578

Date of Patent

March 5, 2013

Patent Application Number

11286448

Date Filed

November 23, 2005

Patent Citations Received

‌

US Patent 12110552 Methods for simultaneous amplification of target loci

‌

US Patent 12024738 Methods for cancer detection and monitoring

‌

US Patent 12065703 System and method for cleaning noisy genetic data and determining chromosome copy number

‌

US Patent 12084720 Assessing graft suitability for transplantation

‌

US Patent 11746376 Methods for amplification of cell-free DNA using ligated adaptors and universal and inner target-specific primers for multiplexed nested PCR

‌

US Patent 11833121 Composition and method for treating neurological disease

‌

US Patent 11890261 Composition and method for treating neurological disease

‌

US Patent 11903908 Methods of administering amantadine

...

Patent Primary Examiner

‌

Paul Zarek

Patent abstract

The invention provides methods and compositions for treating or preventing neurological disorders.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8389578 Composition and method for treating neurological disease

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API